Progress
The Indian Army, Department of Military Affairs, invites a supply-only tender for a broad list of pharmaceutical products, including cardiovascular, antidiabetic, antiemetic, antibiotics, and fertility medications. Estimated value is ₹71,975.00, with 28 items referenced in the BOQ. The scope is limited to supply of goods to governmental facilities, with no manufacturing or services tied to delivery. Key differentiator is the extensive drug portfolio under a single procurement with an option clause for quantity variation up to 25% and a flexible delivery framework. The tender emphasizes firm, direct procurement of listed medicines and related tablets, as part of national security pharmacopoeia support. Location is national, targeting Indian Army distribution channels, and the procurement aligns with Department of Military Affairs guidelines.
List of medicines includes: SILDENAFIL CITRATE 20 MG, BISOPROLOL 1.25 MG, LEVONORGESTREL 0.3 MG + ETHINYLESTRADIOL 0.15 MG, REPAGLINIDE 2 MG, TORSEMIDE 10 MG, ACECLOFENAC + THIOCOLCHICOSIDE 4 MG, DAPAGLIFLOZIN combinations with METFORMIN, TELMISARTAN combinations, CILNIDIPINE 5 mg, CILNIDIPINE 10 mg, GLICLAZIDE 60 mg with METFORMIN 500 mg, among others
Quantity: 28 items in BOQ; precise quantities not listed in data
Estimated value: ₹71,975.00
Delivery: Supply of goods only; no service/installation mentioned
Standards: Not specified in data; bidders should anticipate standard pharmaceutical procurement compliance
Quantity variation up to 25% of bid quantity at contract award
Delivery period calculations include a minimum 30 days for extended delivery
Supply-only scope; no manufacturing/service components outlined
Not explicitly specified in data; typical government terms require milestone/ND invoice upon delivery; confirm with buyer
Delivery starts after the last date of the original delivery order; extended delivery time follows the option clause formula
Not specified in data; verify LD clauses in final terms
Eligibility for pharmaceutical supply to government entities
Ability to supply 28 listed medicines and maintain stock purity
Compliance with standard bidder documentation (GST, PAN, experience, financials)
Quantity
7615
Category
XANTINOL NICOTINATE SR 500 COMPLAMINA RETARD
Bid Type
Two Packet Bid
Bid Validity
90 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
Tech Clarification Time
2 Days
EMD Required
No
MII Purchase Preference
No
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
XANTINOL NICOTINATE SR 500 COMPLAMINA RETARD , TAB SILDENAFIL CITRATE 25 MG , BISOPROLOL 1 POINT 25MG TAB , LEVONORGESTREL 0 POINT 3MG PLUS ETHINYLESTRADIOL 0 POINT 15MG PACK OF 21 TAB , REPAGLINIDE 2 MG TAB , Tab EPLERENONE 25 MG PLUS TORSEMIDE 10 MG PLANEP T , TAB ACOTIAMIDE 100 , TAB RIFAMPICIN 150 PLUS ISONIAZID 75 PLUS PYRAZINAMIDE 400 PLUS ETHAMBUTOL 275 AKURIT 4 , TAB ACECLOFENAC PLUS THIOCOLCHICOSIDE 4 MG , TAB AMILORIDE PLUS FRUSEMIDE , TAB SILDINAFIL CITRATE 20 , TAB ATORVASTATIN 10 PLUS CLOPIDOGREL 75 , TAB BILASTIN 20 , TAB BUSPIRONE HYDROCHLORIDE 10 , TAB CILNIDIPINE 5 , TAB CILNIDIPIN 10 PLUS TELMISARTAN 40 , TAB CLONOTRIL 0 POINT 5 , TAB CEREBROPROTEIN 90 , TAB CHLORTHALIDONE 6 POINT 25 , TAB CTD PLUS TELMISARTAN PLUS AMLODIPINE 6 POINT 25 AND 40 AND 5 , TAB GLICLAZIDE 60 , TAB GLICLAZIDE 60 PLUS METFORMIN 500 , TAB DAPAGLIFLOZIN 10 PLUS METFORMIN 500 , TAB DAPAGLIFLOZIN 5 PLUS METFORMIN 500 , TAB DILTIAZAM 120 , TAB DESVENLAFAXINE 100 , TAB DYDROGESTERONE 10 , TAB DISULFIRAM 250
Max Delivery Days
21
Delivery Locations
1
Delivery Cities
HYDERABAD
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | HYDERABAD | HYDERABAD | - | - | 200 | 21 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
XANTINOL NICOTINATE SR 500 COMPLAMINA RETARD
NO
TAB SILDENAFIL CITRATE 25 MG
TAB
BISOPROLOL 1 POINT 25MG TAB
TAB
LEVONORGESTREL 0 POINT 3MG PLUS ETHINYLESTRADIOL 0 POINT 15MG PACK OF 21 TAB
TAB
REPAGLINIDE 2 MG TAB
TAB
Tab EPLERENONE 25 MG PLUS TORSEMIDE 10 MG PLANEP T
TAB
TAB ACOTIAMIDE 100
TAB
TAB RIFAMPICIN 150 PLUS ISONIAZID 75 PLUS PYRAZINAMIDE 400 PLUS ETHAMBUTOL 275 AKURIT 4
TAB
TAB ACECLOFENAC PLUS THIOCOLCHICOSIDE 4 MG
TAB
TAB AMILORIDE PLUS FRUSEMIDE
TAB
TAB SILDINAFIL CITRATE 20
TAB
TAB ATORVASTATIN 10 PLUS CLOPIDOGREL 75
TAB
TAB BILASTIN 20
TAB
TAB BUSPIRONE HYDROCHLORIDE 10
TAB
TAB CILNIDIPINE 5
TAB
TAB CILNIDIPIN 10 PLUS TELMISARTAN 40
TAB
TAB CLONOTRIL 0 POINT 5
TAB
TAB CEREBROPROTEIN 90
TAB
TAB CHLORTHALIDONE 6 POINT 25
TAB
TAB CTD PLUS TELMISARTAN PLUS AMLODIPINE 6 POINT 25 AND 40 AND 5
TAB
TAB GLICLAZIDE 60
TAB
TAB GLICLAZIDE 60 PLUS METFORMIN 500
TAB
TAB DAPAGLIFLOZIN 10 PLUS METFORMIN 500
TAB
TAB DAPAGLIFLOZIN 5 PLUS METFORMIN 500
TAB
TAB DILTIAZAM 120
TAB
TAB DESVENLAFAXINE 100
TAB
TAB DYDROGESTERONE 10
TAB
TAB DISULFIRAM 250
TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | XANTINOL NICOTINATE SR 500 COMPLAMINA RETARD | NO | 200 | n0 | ms18473f | 21 | |
| 2 | TAB SILDENAFIL CITRATE 25 MG | TAB | 400 | n0 | ms18473f | 21 | |
| 3 | BISOPROLOL 1 POINT 25MG TAB | TAB | 300 | n0 | ms18473f | 21 | |
| 4 | LEVONORGESTREL 0 POINT 3MG PLUS ETHINYLESTRADIOL 0 POINT 15MG PACK OF 21 TAB | TAB | 15 | n0 | ms18473f | 21 | |
| 5 | REPAGLINIDE 2 MG TAB | TAB | 300 | no | ms18473f | 21 | |
| 6 | Tab EPLERENONE 25 MG PLUS TORSEMIDE 10 MG PLANEP T | TAB | 450 | no | ms18473f | 21 | |
| 7 | TAB ACOTIAMIDE 100 | TAB | 200 | no | ms18473f | 21 | |
| 8 | TAB RIFAMPICIN 150 PLUS ISONIAZID 75 PLUS PYRAZINAMIDE 400 PLUS ETHAMBUTOL 275 AKURIT 4 | TAB | 150 | no | ms18473f | 21 | |
| 9 | TAB ACECLOFENAC PLUS THIOCOLCHICOSIDE 4 MG | TAB | 100 | no | ms18473f | 21 | |
| 10 | TAB AMILORIDE PLUS FRUSEMIDE | TAB | 100 | no | ms18473f | 21 | |
| 11 | TAB SILDINAFIL CITRATE 20 | TAB | 200 | no | ms18473f | 21 | |
| 12 | TAB ATORVASTATIN 10 PLUS CLOPIDOGREL 75 | TAB | 300 | no | ms18473f | 21 | |
| 13 | TAB BILASTIN 20 | TAB | 500 | no | ms18473f | 21 | |
| 14 | TAB BUSPIRONE HYDROCHLORIDE 10 | TAB | 200 | no | ms18473f | 21 | |
| 15 | TAB CILNIDIPINE 5 | TAB | 450 | no | ms18473f | 21 | |
| 16 | TAB CILNIDIPIN 10 PLUS TELMISARTAN 40 | TAB | 300 | no | ms18473f | 21 | |
| 17 | TAB CLONOTRIL 0 POINT 5 | TAB | 100 | no | ms18473f | 21 | |
| 18 | TAB CEREBROPROTEIN 90 | TAB | 300 | no | ms18473f | 21 | |
| 19 | TAB CHLORTHALIDONE 6 POINT 25 | TAB | 600 | no | ms18473f | 21 | |
| 20 | TAB CTD PLUS TELMISARTAN PLUS AMLODIPINE 6 POINT 25 AND 40 AND 5 | TAB | 200 | no | ms18473f | 21 | |
| 21 | TAB GLICLAZIDE 60 | TAB | 750 | no | ms18473f | 21 | |
| 22 | TAB GLICLAZIDE 60 PLUS METFORMIN 500 | TAB | 200 | no | ms18473f | 21 | |
| 23 | TAB DAPAGLIFLOZIN 10 PLUS METFORMIN 500 | TAB | 400 | no | ms18473f | 21 | |
| 24 | TAB DAPAGLIFLOZIN 5 PLUS METFORMIN 500 | TAB | 300 | no | ms18473f | 21 | |
| 25 | TAB DILTIAZAM 120 | TAB | 200 | no | ms18473f | 21 | |
| 26 | TAB DESVENLAFAXINE 100 | TAB | 200 | no | ms18473f | 21 | |
| 27 | TAB DYDROGESTERONE 10 | TAB | 100 | no | ms18473f | 21 | |
| 28 | TAB DISULFIRAM 250 | TAB | 100 | no | ms18473f | 21 |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates in pharmaceutical supply (if required by terms)
Financial statements or turnover documentation
EMD deposit proof (if requested by terms)
Technical bid / product compliance certificates
OEM authorizations or preferred supplier declarations
Key insights about TELANGANA tender market
Bidders must submit standard corporate documents (GST, PAN, financials) and provide proof of capability to supply 28 listed medicines. Ensure compliance with Department of Military Affairs procurement rules, offer for supply-only, and be prepared for quantity variation up to 25% with extended delivery as calculated by the formula. Clarify any EMD requirements with the buyer.
Submit GST certificate, PAN card, experience certificates in pharmaceutical supply, financial statements, and technical bid documents. OEM authorizations may be required if bidding as an authorized distributor. Provide delivery capability proof, and confirm any EMD deposits per buyer terms; ensure product compliance with national pharmacopeial standards.
The tender covers 28 listed medicines including SILDENAFIL CITRATE 20 MG, BISOPROLOL 1.25 MG, LEVONORGESTREL 0.3 MG with ETHINYLESTRADIOL 0.15 MG, REPAGLINIDE 2 MG, TORSEMIDE 10 MG, and combinations like TELMISARTAN with AMLODIPINE. Precise item quantities are in the BOQ; bidders must prepare stock accordingly to meet delivery timelines.
Delivery is supply-only with an option to increase/decrease quantity by up to 25%. The delivery period begins from the last date of the original delivery order, and extended time is (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days. Ensure readiness for staged deliveries as per original and extended orders.
Prepare for ±25% variation in contracted quantity. The formula for extended delivery time is applied, with a minimum 30-day extension. Ensure current stock levels can flex to higher/lower demand, and price quotes reflect potential quantity changes at contracted rates.
The tender data does not specify explicit standards; bidders should anticipate standard government pharmaceutical procurement norms, GMP-like compliance, and product conformity documentation. Verify IS/ISO or pharmacopeia alignment with the buyer during final terms and obtain relevant compliance certificates.
The tender data does not provide a submission deadline. Bidders should contact the Indian Army procurement office or check the official tender portal immediately for notification updates, submission windows, and any amendments. Prepare all required documents in advance to avoid delays.
The estimated value is ₹71,975.00 for the 28-item medicines list. This figure indicates a compact procurement scope, suggesting a focus on essential medicines stock. Vendors should price per item carefully to reflect potential quantity variations and delivery costs under the option clause.